We rely on donations from people like you to fund our research programs.
AIDS Research Alliance is a 501(c)(3) non-profit organization, every gift, large or small, is tax-deductible and moves our research forward.
Please join us as we strive to realize an HIV-free generation. Please support our work. Thank you.

We won’t stop until we’ve eradicated HIV/AIDS

Join the Alliance!

Banner

Prostratin Moves Forward: New Scientist Joins ARA’s Cure Research Team

Stefanie_Homann_200 After an extensive search that attracted candidates from around the world, AIDS Research Alliance has hired Stefanie Homann, Ph.D. to lead its research team and advance its HIV cure research. Dr. Homann joins ARA from the laboratory of Dr. John Guatelli, M.D., Division of Infectious Diseases at the University of California, San Diego. In Guatelli’s lab, Dr. Homann conducted postdoctoral research on HIV infection – performing both ex vivo and in vitro experiments... Read More





HIV Infection Rates in Latinos and Why We Need a Vaccine

latinohiv For more than three decades, HIV/AIDS has had a tremendous impact in communities around the world and in the United States, including the Latino community in Los Angeles County.  According to the Centers for Disease Control (CDC), in 2009 (the year of the most recent data available from the CDC), Latinos accounted for 20% of the new HIV infections while representing approximately 16% of the total US population. The HIV infection rate among Latinos in 2009 was... Read More





Petroleum Jelly Use Linked to STI Risk

vaseline_200x120 If you are a woman, using petroleum jelly as a lubricant could increase your risk of contracting bacterial vaginosis. One of the first studies on women’s intravaginal product use, conducted here at AIDS Research Alliance and published in the April issue of Obstetrics & Gynecology, indicates that the use of petroleum jelly as a female lubricant is associated with a more-than-twofold increase in a woman’s chances of having bacterial vaginosis. Bacterial vaginosis, a... Read More





NIH Discontinues Vaccinations in HIV Vaccine Study

vaccine_200x120 AIDS Research Alliance (ARA) has discontinued administering the HIV Vaccine Trials Network (HVTN) 505 HIV vaccine candidate, as preliminary data indicate that the vaccine strategy is ineffective. Read More





Dr. David Hardy Joins ARA Board; Brings 30+ Years HIV Experience

Hardy_200x120 AIDS Research Alliance is pleased to announce the addition of a very experienced HIV researcher and physician to our Board of Directors. Dr. David Hardy, the Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center, and Professor of Medicine at the David Geffen School of Medicine at UCLA, has been a supporter of AIDS Research Alliance for many years. As a Board member, he will bring more than 30 years of HIV medical experience—... Read More





Page 6 of 15 pages ‹ First  < 4 5 6 7 8 >  Last ›